newsfilter
← Latest News
FDA Approved Drugs·

Approval of Lytenava, Bla #761320

Approval Date: 07/24/2026; Drug Name: Lytenava, Bla #761320; Active Ingredients: BEVACIZUMAB-VIKG; Company: Outlook Therapeutics, Inc.; Submission Status: Approval; Application Number: 761320

Company
OUTLOOK THERAPEUTICS, INC.
Keywords
OUTLOOK THERAPEUTICS, INC.